EE254 The Cost-Consequence of Budesonide/Formoterol Plus As-Needed Saba As Treatment for 6-12 Years Old Pediatric Asthma Patients in ChinaBased on Real-World Data
Abstract
Authors
C Zuo Y Jiang K Zhou X Xie J Xuan
C Zuo Y Jiang K Zhou X Xie J Xuan
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now